Product Images Atorvastatin Calcium

The text describes a graph showing the cumulative incidence in percentage over the years. It displays two data points: Aovastatn at 15% and an unidentified variable at 40%. There is also a numeric code, HR-084 050089, and a p-value of 0.0005.*

This document seems to be presenting the results of a study involving Atorvastatin treatment on patients. The term "Cumulative Hazard" and the percentages (15 and 10) are likely related to the probability of developing adverse effects or complications over time. The drug Atorvastatin is mentioned in the middle of the page along with some numerical values, and the letters "HR" may indicate hazard ratio, which may be further elaborated on in the document. The bottom of the page seems to be displaying a graph, possibly showing the probability of experiencing a certain primary endpoint over the course of four years.*

This is a result from a study on the effects of two doses of a drug, sorvastatin (10mg and 80mg), compared to a placebo in a group of subjects. The text shows the percentage of subjects who experienced vertigo, and the hazard ratio (HR) and p-value for the time to first major cardiovascular endpoint. It appears that the HR for the 80mg dose group was 0.78, indicating a lower risk of experiencing the endpoint compared to the placebo, with a statistically significant p-value of 0.0002. The graph shows time (in years) to the first cardiovascular endpoint for the different treatment groups.*

The text provides information about a medication named Atorvastatin Calcium in the form of tablets. Each tablet contains 20mg of Atorvastatin Galcium. There are 30 tablets in each package and the package has a product ID QA026130. The tablets are white, oval shaped with "PD155" on one side and "20" on the other. The manufacturer of the tablets is Pfizer Pharmaceuticals LLC located in Puerto Rico.*